Herpes Zoster Ophthalmicus (Ocular Shingles)
Herpes zoster ophthalmicus, also known as ocular shingles, is an infection caused by the varicella-zoster virus (VZV), the same virus responsible for chickenpox. The virus can remain dormant in the body for many years after an outbreak of chickenpox and may reactivate at another point in time. Commonly resulting in rashes on the body, shingles can also affect the eyes.
When the virus reactivates, it usually travels through nerve fibers to infect other parts of the body. The virus may travel to the upper part of the body, affecting the head and the neck. Almost 50 percent of those affected with shingles, in the head and neck area, have corneas that are infected with the virus.
Ocular shingles can occur in anyone exposed to the varicella-zoster virus but people with weakened immune systems or over 80 years of age and older have an increased risk of developing the illness.
Symptoms of Ocular Shingles
Ocular shingles often produces extreme pain on one side of the face, a rash or redness developing in the eye region or on the forehead, eye redness, inflammation of the eye and vision problems. If left untreated, ocular shingles can lead to the following:
- Corneal infection
- Corneal scarring
- Retinitis
- Glaucoma
- Significant vision loss
Treatment of Ocular Shingles
Ocular shingles of the eye is often treated with antiviral eye drops or oral medication, depending on the area of the eye that is affected. If the medication is not administered within the first few days of the appearance of symptoms, it may not be effective. In some cases, steroid eye drops may be prescribed to relieve swelling. An ophthalmologist or cornea specialist should be consulted in order to manage this condition.
SHINGRIX Vaccine | Protection against shingles
The SHINGRIX vaccine is an essential tool in preventing herpes zoster, commonly known as shingles. Herpes zoster is caused by the reactivation of the varicella-zoster virus, the same virus responsible for chickenpox. After a person recovers from chickenpox, the virus can lie dormant in the body and reactivate later in life, resulting in shingles.
SHINGRIX offers robust protection against herpes zoster, significantly reducing the risk of developing this painful condition. By receiving the two-dose series of the SHINGRIX vaccine, individuals can build a strong defense against the reactivation of the varicella-zoster virus, providing peace of mind and reducing the potential complications associated with shingles.
The vaccine’s effectiveness in preventing herpes zoster has been extensively studied, with clinical trials demonstrating its high efficacy rate of over 90%. Additionally, SHINGRIX has been proven to be effective across various age groups, making it a valuable preventive measure for adults aged 50 years and older.
By choosing to receive the SHINGRIX vaccine, you are taking a proactive step towards protecting yourself from the discomfort and potential long-term effects of herpes zoster. Consult with our healthcare professionals today to learn more about the benefits of the SHINGRIX vaccine and schedule your vaccination appointment.
Note: The SHINGRIX vaccine is recommended for individuals aged 50 years and older. Please consult with your healthcare provider for personalized advice and guidance based on your specific health circumstances.
